Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which nerve block helps patients recover faster after laparoscopic surgery?

NCT ID NCT07720817

Symptom relief Sponsor: Mansoura University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Sep 17, 2026 · Updated 5 times

Summary

This trial compares two ultrasound-guided nerve blocks—retrolaminar block and transverse abdominis plane (TAP) block—to see which one improves recovery and reduces pain after laparoscopic upper abdominal surgery. About 164 adults aged 21 to 65 will receive one of the two blocks before surgery. The goal is to determine which approach leads to better pain control, less need for painkillers, and a smoother recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound-guided nerve blocks (retrolaminar block or transverse abdominis plane block) using a local anesthetic
What this could lead to
If one block proves superior, it could become the preferred method for managing pain and speeding recovery after laparoscopic abdominal surgery.
What could go wrong
This is a single-center trial with a moderate sample size, so results may not apply to all patients or surgical settings. Nerve blocks carry risks like bleeding, infection, or incomplete pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 164 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 21 and 65 years. * American Society of Anesthesiologists (ASA) physical status I or II. * Body mass index (BMI) less than 30 kg/m². * Scheduled for elective laparoscopic upper abdominal surgery under general anesthesia. Exclusion Criteria: * Refusal to participate in the study. * Known allergy or hypersensitivity to any of the study drugs. * Infection at the planned block insertion site. * Severe uncontrolled cardiac, renal, hepatic, neurological, or respiratory disease. * Pre-existing chronic pain. * Immunodeficiency. * Coagulation abnormalities, anticoagulant therapy, or platelet count less than 80,000/µL. * Emergency surgery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laparoscopic abdominal surgeries are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Laparoscopic abdominal surgeries Retrolaminar block Tap block

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mansoura University

    RECRUITING

    Al Mansurah, Dakahlia Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.